Leukaemia Cancer Acute lymphoblastic leukaemia
Conditions
Interventions
Central Nervous System (CNS) directed chemotherapy/control
Sponsors
Medical Research Council (MRC) (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: They are children including those with Down's syndrome or leukaemia associated chromosome translocations over 1 year and under 15 years with newly diagnosed ALL of any immunologic subtype except B-ALL
Exclusion criteria
Exclusion criteria: Children with B-ALL and those under 1 year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival, CNS disease eradication, relapse rates, psychometric test results. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
England, United Kingdom
Outcome results
None listed